エストニア - エストニア語 - Ravimiamet

viatris limited - apiksabaan - õhukese polümeerikattega tablett - 2,5mg 168tk; 2,5mg 120tk; 2,5mg 1000tk; 2,5mg 56tk; 2,5mg 100tk; 2,5mg 200tk; 2,5mg 20tk; 2,5mg 10tk

エストニア - エストニア語 - Ravimiamet

viatris limited - apiksabaan - õhukese polümeerikattega tablett - 5mg 1000tk; 5mg 20tk; 5mg 100tk; 5mg 200tk; 5mg 60tk; 5mg 180tk; 5mg 168tk; 5mg 14tk; 5mg 56tk

エストニア - エストニア語 - Ravimiamet

viatris limited - apiksabaan - õhukese polümeerikattega tablett - 5mg 120tk; 5mg 200tk; 5mg 28tk; 5mg 180tk; 5mg 100tk; 5mg 1000tk; 5mg 20tk; 5mg 56tk

エストニア - エストニア語 - Ravimiamet

viatris limited - apiksabaan - õhukese polümeerikattega tablett - 2,5mg 200tk; 2,5mg 56tk; 2,5mg 100tk; 2,5mg 60tk; 2,5mg 180tk; 2,5mg 20tk; 2,5mg 10tk; 2,5mg 1000tk

欧州連合 - エストニア語 - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunoloogilised ained - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

欧州連合 - エストニア語 - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kana - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

エストニア - エストニア語 - Ravimiamet

krka d.d. novo mesto - apiksabaan - õhukese polümeerikattega tablett - 2,5mg 14tk; 2,5mg 28tk; 2,5mg 20tk; 2,5mg 56tk; 2,5mg 200tk; 2,5mg 60tk

エストニア - エストニア語 - Ravimiamet

krka d.d. novo mesto - apiksabaan - õhukese polümeerikattega tablett - 5mg 28tk; 5mg 100tk; 5mg 20tk; 5mg 10tk; 5mg 200tk; 5mg 60tk; 5mg 56tk

欧州連合 - エストニア語 - EMA (European Medicines Agency)

sanofi b.v. - olipudase alfa - acid sphingomyelinase deficiency (asmd) type a/b or type b - muud alimentary seedetrakti ja ainevahetust tooted, - xenpozyme is indicated as an enzyme replacement therapy for the treatment of non-central nervous system (cns) manifestations of acid sphingomyelinase deficiency (asmd) in paediatric and adult patients with type a/b or type b.

欧州連合 - エストニア語 - EMA (European Medicines Agency)

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaktsiinid - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.